What, if any, JAK inhibitors (oral or topical) have you found most helpful in treating bullous pemphigoid?

What dosing range do you typically prescribe?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

How do you manage pemphigus vulgaris in patients who lack insurance coverage for biologics and routine laboratory monitoring?

Does the presence of paraneoplastic pemphigus influence your treatment options in CLL?

Should nivolumab be discontinued in a patient who develops bullous pemphigoid but is otherwise responding well to therapy, if BP is being managed with dupilumab?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.